Endeavor BioMedicines

Drug Discovery

Endeavor BioMedicines is a private drug discovery company. It has raised $133 million across 2 recorded rounds; the latest was a $133 million Series C in Apr 2024.

PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$132.5M
Last round
Later Stage VC (Series C)
Apr 2024
How much has Endeavor BioMedicines raised?
$132.5Macross 2 recorded rounds · Jan 2022 – Apr 2024

Most recently, Endeavor BioMedicines raised $132.5M in its Later Stage VC (Series C) (Apr 2024).

Free account
More of Endeavor BioMedicines with a free account
  • ·Watch Endeavor BioMedicines: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Endeavor BioMedicines round by round

2 rounds
Apr 2024Later Stage VC (Series C)$132.5M▮
+ 1 more investors · free account
Jan 2022Later Stage VC$89.1MSEC filing▮
16 investors participated

How much has Endeavor BioMedicines raised?

Endeavor BioMedicines has raised $133 million across 2 recorded rounds since 2022. The largest was an $89.1 million later-stage round in Jan 2022; the most recent was a $133 million Series C in Apr 2024.

Endeavor BioMedicines has filed 2 Form Ds with the SEC since 2022, most recently in May 2024 ($133 million sold to 32 investors).

Frequently asked about Endeavor BioMedicines

How much has Endeavor BioMedicines raised?
Endeavor BioMedicines has raised $132.5M in total across 2 recorded funding rounds.
When was Endeavor BioMedicines's last funding round?
Endeavor BioMedicines's most recent recorded round was Later Stage VC (Series C) in Apr 2024, raising $132.5M.